HologicHOLXEarnings & Financial Report
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
HOLX Q1 FY2026 Key Financial Metrics
Revenue
$1.0B
Gross Profit
$586.4M
Operating Profit
$237.0M
Net Profit
$179.1M
Gross Margin
56.0%
Operating Margin
22.6%
Net Margin
17.1%
YoY Growth
2.5%
EPS
$0.79
Hologic Q1 FY2026 Financial Summary
Hologic reported revenue of $1.0B (up 2.5% YoY) for Q1 FY2026, with a net profit of $179.1M (down 10.9% YoY) (17.1% margin). Cost of goods sold was $461.4M, operating expenses totaled $349.4M.
Key Financial Metrics
| Total Revenue | $1.0B |
|---|---|
| Net Profit | $179.1M |
| Gross Margin | 56.0% |
| Operating Margin | 22.6% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Hologic Q1 FY2026 revenue of $1.0B breaks down across 8 segments, led by Molecular Diagnostics at $255.3M (24.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Molecular Diagnostics | $255.3M | 24.4% |
| Breast Imaging | $219.9M | 21.0% |
| Services | $216.4M | 20.7% |
| Capital Equipment Componentsand Software | $187.2M | 17.9% |
| Cytology Perinatal | $76.0M | 7.3% |
| Interventional Breast Solutions | $71.2M | 6.8% |
| Blood Screening | $8.4M | 0.8% |
| Other Typeof Revenue | $5.4M | 0.5% |
Hologic Revenue by Segment — Quarterly Trend
Hologic revenue by segment across the last 4 reported quarters, showing how each business line (such as Molecular Diagnostics and Breast Imaging) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Molecular Diagnostics | $255.3M | $252.7M | $254.4M | $258.7M |
| Breast Imaging | $219.9M | $230.9M | $204.2M | $209.4M |
| Services | $216.4M | $214.5M | $213.4M | $212.6M |
| Capital Equipment Componentsand Software | $187.2M | $176.4M | $152.0M | $155.8M |
| Cytology Perinatal | $76.0M | $73.2M | $75.8M | — |
Hologic Annual Revenue by Year
Hologic annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.1B).
Hologic Quarterly Revenue & Net Profit History
Hologic results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.0B | +2.5% | $179.1M | 17.1% |
| Q4 FY2025 | $1.0B | +6.2% | $187.2M | 17.8% |
| Q3 FY2025 | $1.0B | +1.2% | $194.9M | 19.0% |
| Q2 FY2025 | $1.0B | -1.2% | $-17.4M | -1.7% |
| Q1 FY2025 | $1.0B | +0.9% | $201.0M | 19.7% |
| Q4 FY2024 | $988.0M | +0.4% | $178.6M | 18.1% |
| Q3 FY2024 | $1.0B | -1.5% | $194.5M | 19.2% |
| Q2 FY2024 | $1.0B | -0.8% | $169.9M | 16.7% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | $1.01B | $988.0M | $1.02B | $1.01B | $1.02B | $1.05B | $1.05B |
| YoY Growth | -0.8% | -1.5% | 0.4% | 0.9% | -1.2% | 1.2% | 6.2% | 2.5% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $8.71B | $8.89B | $9.16B | $8.73B | $8.55B | $8.81B | $9.01B | $9.18B |
| Liabilities | $3.87B | $3.94B | $4.03B | $3.96B | $3.93B | $3.96B | $3.97B | N/A |
| Equity | $4.84B | $4.95B | $5.13B | $4.77B | $4.62B | $4.84B | $5.05B | $5.25B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $292.4M | $405.8M | $367.0M | $189.3M | $169.4M | $343.3M | $355.1M | $229.9M |